法国政府消息人士在周日指出，法国制药厂赛诺菲(Sanofi)已经达成协议，将旗下消费者健康部门Opella的控股权出售给美国私募股权公司CD&R(Clayton Dubilier & Rice)。消息人士指出，在赛诺菲、CD&R和法国政府三方进行 ...

Sanofi is increasing its R&D presence in China, announcing plans to open a global research hub focused on data analysis in Chengdu. The French firm said this confirms China as the “third pillar ...

The French government has taken a small stake in Sanofi's consumer healthcare business Opella, following political backlash ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Plus, news about TenNor Therapeutics, Gan & Lee Pharmaceuticals, Orasis and Optus Pharmaceuticals: Exscientia receives $15M milestone from Sanofi: The companies are advancing two programs as ...

French drugmaker Sanofi’s confirmation yesterday that it plans to sell a controlling stake in its over-the-counter unit to a ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes ...

France is considering taking a stake in Sanofi's Opella arm, said finance minister Antoine Armand, to allay concerns that the ...

Sanofi (EPA: SASY)(NASDAQ: SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier & Rice to sell a controlling stake in its consu ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing. Sanofi has entered negotiations with private ...